Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0WB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,081
Award facts
- Contract value 100% obligated
- $26,080.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $26,080.77. This firm fixed-price delivery order, which is not set aside for small business or other designated groups, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. Zepbound is a weight management pharmaceutical, indicating this contract supports federal healthcare supply needs for military and defense personnel.
This delivery order is a child contract issued under AmerisourceBergen's $999.99 billion IDC with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts covering a broad range of medications, medical devices, and healthcare commodities across multiple therapeutic domains. The company's significant IDC authority enables it to efficiently fulfill federal medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FA0WB?
SPE2DR26FA0WB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FA0WB worth?
The government has obligated $26,081 on SPE2DR26FA0WB.
Is contract SPE2DR26FA0WB an order under another contract?
Yes. SPE2DR26FA0WB is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0WB competed?
The extent of competition for SPE2DR26FA0WB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award